Overview

Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This is a comparative study to assess bioavailability of a proposed alternate dosage form against the current FDA-approved branded product.
Phase:
Phase 1
Details
Lead Sponsor:
INSYS Therapeutics Inc
Treatments:
Dronabinol
Pharmaceutical Solutions